Anelik bank places bonds ahead of schedule

YEREVAN, May 30. /ARKA/. The Yerevan-based Anelik Bank said today that its second issue of nominal USD-denominated coupon bonds at Nasadq OMX Armenia stock exchange was fully placed ahead of schedule.

The second issue of bonds is worth $5 million; the maturity period is 24 months; the coupon yield is 6.25%, while interest is paid every six months. The bonds were acquired by individuals and legal entities in Yerevan and beyond it.

The bank said more than 80% of the bonds were bought by individuals, indicating a high level of public trust in the bank and its financial literacy. Anelik Bank financial officer Ruben Melikyan is quoted as saying in a press release that the bank plans to issue new tranches of bonds.

Anelik Bank was established on July 9, 1990. It is now owned by FISTOCO LTD – 59.7% and CreditBank S.A.L. – 40.3%. –0–

spot_img

POPULAR

Armbanks Weekly Digest: Key Events in the Armenian Financial Market (August 17–23)

Key developments in Armenia's financial market this week included new banking compliance requirements, measures against account fraud, and decisions related to capital market development.

S&P affirms Armenia’s ratings, maintaining a positive outlook

The international rating agency S&P Global Ratings affirmed the long- and short-term sovereign ratings of the Republic of Armenia at 'BB-/B', maintaining a positive outlook, the Ministry of Finance reported.

The investment portfolio of Armenian banks in the second quarter amounted to 1.93 trillion drams, a decline of 9.5% year-to-date

The total investment portfolio of commercial banks in Armenia at the end of June 2026 amounted to 1,933,341,220 thousand drams, a decrease of 202.38 billion drams, or 9.48%, year-to-date.

Armenia’s public debt will remain stable at just above 40% in the medium term – S&P

Armenia's public debt (excluding liquid assets) will remain broadly stable at just above 40% of GDP in the medium term, according to a report from the international rating agency S&P Global Ratings.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img